TY - JOUR
T1 - Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors
AU - Takaoka, Akinori
AU - Yanai, Hideyuki
AU - Kondo, Seiji
AU - Duncan, Gordon
AU - Negishi, Hideo
AU - Mizutani, Tatsuaki
AU - Kano, Shin Ichi
AU - Honda, Kenya
AU - Ohba, Yusuke
AU - Mak, Tak W.
AU - Taniguchi, Tadatsugu
PY - 2005/3/10
Y1 - 2005/3/10
N2 - The activation of Toll-like receptors (TLRs) is central to innate and adaptive immunity1-3. All TLRs use the adaptor MyD88 for signalling4, but the mechanisms underlying the MyD88-mediated gene induction programme are as yet not fully under-stood. Here, we demonstrate that the transcription factor IRF-5 is generally involved downstream of the TLR-MyD88 signalling pathway for gene induction of proinflammatory cytokines, such as interleukin-6 (IL-6), IL-12 and tumour-necrosis factor-α. In haematopoietic cells from mice deficient in the Irf5 gene (Irf5-/- mice), the induction of these cytokines by various TLR ligands is severely impaired, whereas interferon-α induction is normal. We also provide evidence that IRF-5 interacts with and is activated by MyD88 and TRAF6, and that TLR activation results in the nuclear translocation of IRF-5 to activate cytokine gene transcription. Consistently, Irf5-/- mice show resistance to lethal shock induced by either unmethylated DNA or lipopolysaccharide, which correlates with a marked decrease in the serum levels of proinflammatory cytokines. Thus, our study identifies IRF-5 as a new, principal downstream regulator of the TLR-MyD88 signalling pathway and a potential target of therapeutic intervention to control harmful immune responses.
AB - The activation of Toll-like receptors (TLRs) is central to innate and adaptive immunity1-3. All TLRs use the adaptor MyD88 for signalling4, but the mechanisms underlying the MyD88-mediated gene induction programme are as yet not fully under-stood. Here, we demonstrate that the transcription factor IRF-5 is generally involved downstream of the TLR-MyD88 signalling pathway for gene induction of proinflammatory cytokines, such as interleukin-6 (IL-6), IL-12 and tumour-necrosis factor-α. In haematopoietic cells from mice deficient in the Irf5 gene (Irf5-/- mice), the induction of these cytokines by various TLR ligands is severely impaired, whereas interferon-α induction is normal. We also provide evidence that IRF-5 interacts with and is activated by MyD88 and TRAF6, and that TLR activation results in the nuclear translocation of IRF-5 to activate cytokine gene transcription. Consistently, Irf5-/- mice show resistance to lethal shock induced by either unmethylated DNA or lipopolysaccharide, which correlates with a marked decrease in the serum levels of proinflammatory cytokines. Thus, our study identifies IRF-5 as a new, principal downstream regulator of the TLR-MyD88 signalling pathway and a potential target of therapeutic intervention to control harmful immune responses.
UR - http://www.scopus.com/inward/record.url?scp=15044345461&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=15044345461&partnerID=8YFLogxK
U2 - 10.1038/nature03308
DO - 10.1038/nature03308
M3 - Article
C2 - 15665823
AN - SCOPUS:15044345461
VL - 434
SP - 243
EP - 249
JO - Nature Cell Biology
JF - Nature Cell Biology
SN - 1465-7392
IS - 7030
ER -